| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 6 | 2025 | 246 | 2.110 |
Why?
|
| Hepatoblastoma | 7 | 2024 | 183 | 1.940 |
Why?
|
| Liver Neoplasms | 9 | 2024 | 1405 | 1.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2025 | 2119 | 1.120 |
Why?
|
| MicroRNAs | 11 | 2025 | 949 | 1.010 |
Why?
|
| Gene Expression Profiling | 13 | 2023 | 1911 | 0.920 |
Why?
|
| Computational Biology | 9 | 2024 | 886 | 0.730 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2023 | 995 | 0.690 |
Why?
|
| Transcriptome | 3 | 2023 | 1123 | 0.640 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 959 | 0.540 |
Why?
|
| Gene Regulatory Networks | 6 | 2018 | 396 | 0.530 |
Why?
|
| Neoplasms | 6 | 2024 | 3016 | 0.520 |
Why?
|
| RNA, Messenger | 8 | 2025 | 2899 | 0.500 |
Why?
|
| Neuroblastoma | 4 | 2022 | 539 | 0.500 |
Why?
|
| Receptor, Notch1 | 2 | 2015 | 79 | 0.480 |
Why?
|
| Glioblastoma | 3 | 2018 | 374 | 0.470 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 63 | 0.470 |
Why?
|
| Cell Line, Tumor | 18 | 2025 | 3742 | 0.470 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2025 | 19 | 0.460 |
Why?
|
| Algorithms | 11 | 2015 | 1724 | 0.450 |
Why?
|
| Transcription Factors | 10 | 2019 | 2702 | 0.430 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 585 | 0.390 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2024 | 568 | 0.380 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 1413 | 0.370 |
Why?
|
| Humans | 65 | 2025 | 133573 | 0.370 |
Why?
|
| Sequence Analysis, RNA | 5 | 2023 | 429 | 0.370 |
Why?
|
| Sequence Alignment | 3 | 2015 | 633 | 0.360 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 349 | 0.340 |
Why?
|
| Radiation Tolerance | 3 | 2025 | 67 | 0.310 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2023 | 96 | 0.310 |
Why?
|
| Cytokines | 2 | 2025 | 1396 | 0.310 |
Why?
|
| Oncogenes | 3 | 2018 | 179 | 0.300 |
Why?
|
| Cell Line | 8 | 2021 | 2834 | 0.300 |
Why?
|
| Cell Differentiation | 4 | 2025 | 2024 | 0.290 |
Why?
|
| Animals | 33 | 2025 | 36309 | 0.290 |
Why?
|
| Mice | 24 | 2025 | 18839 | 0.280 |
Why?
|
| Sequence Analysis, DNA | 6 | 2022 | 1834 | 0.280 |
Why?
|
| Sequence Analysis, Protein | 2 | 2004 | 49 | 0.280 |
Why?
|
| Binding Sites | 7 | 2014 | 1369 | 0.270 |
Why?
|
| Mutation | 8 | 2023 | 6280 | 0.270 |
Why?
|
| T-Lymphocytes | 6 | 2024 | 1813 | 0.260 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2018 | 195 | 0.260 |
Why?
|
| Ribonuclease III | 2 | 2025 | 103 | 0.250 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2025 | 147 | 0.240 |
Why?
|
| RNA, Neoplasm | 2 | 2018 | 144 | 0.240 |
Why?
|
| Acrylamides | 1 | 2025 | 24 | 0.240 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2025 | 20 | 0.240 |
Why?
|
| Genome, Human | 3 | 2021 | 1348 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 1070 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2025 | 1002 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 614 | 0.230 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 66 | 0.230 |
Why?
|
| Urinary Catheterization | 1 | 2024 | 57 | 0.230 |
Why?
|
| Glypicans | 1 | 2024 | 41 | 0.230 |
Why?
|
| Receptors, Ghrelin | 1 | 2024 | 28 | 0.220 |
Why?
|
| Wound Healing | 2 | 2025 | 495 | 0.220 |
Why?
|
| Interleukin-15 | 1 | 2024 | 96 | 0.220 |
Why?
|
| Separase | 2 | 2014 | 29 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2025 | 151 | 0.220 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 92 | 0.220 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2015 | 247 | 0.210 |
Why?
|
| Germinal Center | 4 | 2013 | 38 | 0.210 |
Why?
|
| Immunophenotyping | 1 | 2024 | 342 | 0.210 |
Why?
|
| RNA, Untranslated | 2 | 2021 | 120 | 0.210 |
Why?
|
| Cell Survival | 6 | 2025 | 890 | 0.210 |
Why?
|
| Catheter-Related Infections | 1 | 2024 | 104 | 0.210 |
Why?
|
| Piperidines | 1 | 2025 | 238 | 0.210 |
Why?
|
| Rats, Wistar | 1 | 2024 | 400 | 0.200 |
Why?
|
| DNA-Binding Proteins | 4 | 2019 | 2159 | 0.200 |
Why?
|
| Protons | 2 | 2021 | 98 | 0.200 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 231 | 0.200 |
Why?
|
| Sex Characteristics | 1 | 2024 | 335 | 0.190 |
Why?
|
| Signal Transduction | 7 | 2025 | 4888 | 0.190 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 78 | 0.190 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 4752 | 0.190 |
Why?
|
| Prognosis | 7 | 2024 | 5064 | 0.190 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2021 | 9 | 0.190 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2021 | 18 | 0.180 |
Why?
|
| RNA Interference | 2 | 2014 | 540 | 0.180 |
Why?
|
| Urinary Tract Infections | 1 | 2024 | 243 | 0.180 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 711 | 0.180 |
Why?
|
| Oxadiazoles | 1 | 2021 | 25 | 0.180 |
Why?
|
| Consensus Sequence | 2 | 2015 | 57 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 280 | 0.180 |
Why?
|
| Cell Death | 2 | 2019 | 249 | 0.180 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2024 | 884 | 0.170 |
Why?
|
| B-Lymphocytes | 4 | 2013 | 550 | 0.170 |
Why?
|
| Clonal Evolution | 1 | 2020 | 49 | 0.170 |
Why?
|
| Amish | 1 | 2020 | 11 | 0.170 |
Why?
|
| Atovaquone | 1 | 2019 | 10 | 0.170 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 397 | 0.160 |
Why?
|
| Linear Energy Transfer | 1 | 2019 | 9 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2022 | 370 | 0.160 |
Why?
|
| Compulsive Behavior | 1 | 2019 | 41 | 0.160 |
Why?
|
| Base Sequence | 5 | 2018 | 3169 | 0.160 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 38 | 0.160 |
Why?
|
| Genes, BRCA1 | 1 | 2019 | 61 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1792 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 124 | 0.160 |
Why?
|
| Photons | 1 | 2019 | 53 | 0.160 |
Why?
|
| Homologous Recombination | 1 | 2019 | 100 | 0.160 |
Why?
|
| Vaccination | 1 | 2024 | 1010 | 0.160 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 626 | 0.160 |
Why?
|
| AIDS Dementia Complex | 1 | 2019 | 22 | 0.150 |
Why?
|
| Piperazines | 1 | 2021 | 257 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2022 | 230 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2019 | 48 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2023 | 500 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 734 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 131 | 0.150 |
Why?
|
| Fetal Hemoglobin | 1 | 2018 | 28 | 0.150 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2018 | 29 | 0.150 |
Why?
|
| Erythroid Cells | 1 | 2018 | 24 | 0.150 |
Why?
|
| HIV Infections | 2 | 2022 | 2063 | 0.150 |
Why?
|
| Encephalitis | 1 | 2019 | 121 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2021 | 363 | 0.150 |
Why?
|
| Receptor, EphA2 | 1 | 2018 | 29 | 0.150 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2018 | 20 | 0.150 |
Why?
|
| Antigenic Variation | 1 | 2018 | 42 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2017 | 59 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 47 | 0.140 |
Why?
|
| Atazanavir Sulfate | 1 | 2017 | 5 | 0.140 |
Why?
|
| Child | 7 | 2024 | 25740 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 309 | 0.140 |
Why?
|
| Male | 21 | 2025 | 65786 | 0.140 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 774 | 0.140 |
Why?
|
| Liver | 8 | 2021 | 1850 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 225 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 379 | 0.130 |
Why?
|
| Microbiota | 1 | 2022 | 446 | 0.130 |
Why?
|
| Tyrosinemias | 1 | 2016 | 5 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2019 | 245 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 695 | 0.130 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2017 | 140 | 0.130 |
Why?
|
| Rats, Transgenic | 3 | 2022 | 15 | 0.130 |
Why?
|
| Metformin | 1 | 2018 | 162 | 0.130 |
Why?
|
| Quinazolines | 1 | 2017 | 183 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 261 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 790 | 0.130 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1021 | 0.130 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2656 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2021 | 903 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2019 | 424 | 0.120 |
Why?
|
| Genomics | 3 | 2018 | 1672 | 0.120 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2015 | 21 | 0.120 |
Why?
|
| Models, Biological | 3 | 2018 | 1532 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2003 | 1620 | 0.120 |
Why?
|
| Nanog Homeobox Protein | 1 | 2015 | 31 | 0.120 |
Why?
|
| Female | 19 | 2024 | 71546 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 619 | 0.120 |
Why?
|
| HIV-1 | 1 | 2019 | 487 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 808 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 103 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 77 | 0.110 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 559 | 0.110 |
Why?
|
| Apoptosis | 5 | 2021 | 1931 | 0.110 |
Why?
|
| Gene Editing | 1 | 2016 | 205 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1310 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 609 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 286 | 0.110 |
Why?
|
| Young Adult | 3 | 2024 | 9898 | 0.110 |
Why?
|
| Epithelium | 1 | 2014 | 370 | 0.100 |
Why?
|
| Hippocampus | 1 | 2019 | 858 | 0.100 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2024 | 75 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2014 | 183 | 0.100 |
Why?
|
| Rats | 4 | 2024 | 3875 | 0.100 |
Why?
|
| RNA, Transfer | 1 | 2013 | 76 | 0.100 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1716 | 0.100 |
Why?
|
| Software | 2 | 2009 | 736 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2409 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 246 | 0.100 |
Why?
|
| Caveolin 1 | 1 | 2012 | 50 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 873 | 0.090 |
Why?
|
| Child, Preschool | 7 | 2024 | 14787 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2016 | 728 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2014 | 687 | 0.090 |
Why?
|
| Cell Proliferation | 5 | 2019 | 2536 | 0.090 |
Why?
|
| Amino Acid Motifs | 3 | 2010 | 201 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 460 | 0.090 |
Why?
|
| Neurons | 1 | 2021 | 2031 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 150 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2014 | 477 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2010 | 7 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2015 | 867 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2025 | 248 | 0.090 |
Why?
|
| Genes, Regulator | 1 | 2010 | 57 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 716 | 0.080 |
Why?
|
| Protein Domains | 2 | 2023 | 251 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 1487 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 262 | 0.080 |
Why?
|
| Systems Biology | 1 | 2010 | 63 | 0.080 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2009 | 5 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 23 | 0.080 |
Why?
|
| DNA | 1 | 2015 | 1676 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1046 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 395 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2024 | 5175 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 1756 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2018 | 93 | 0.070 |
Why?
|
| Databases, Genetic | 3 | 2018 | 501 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4791 | 0.070 |
Why?
|
| Data Collection | 1 | 2009 | 397 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 382 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2760 | 0.070 |
Why?
|
| Pancreas | 2 | 2025 | 233 | 0.070 |
Why?
|
| Infant | 5 | 2024 | 13149 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 148 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 316 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 472 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 33 | 0.070 |
Why?
|
| Gene Expression | 3 | 2019 | 1614 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 1101 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 317 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 610 | 0.060 |
Why?
|
| Heterografts | 2 | 2017 | 194 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 1069 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1760 | 0.060 |
Why?
|
| Recurrence | 2 | 2023 | 1465 | 0.060 |
Why?
|
| Vertebrates | 1 | 2005 | 41 | 0.060 |
Why?
|
| Gene Silencing | 2 | 2019 | 248 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2019 | 3958 | 0.060 |
Why?
|
| Protein Binding | 4 | 2010 | 1833 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 1398 | 0.060 |
Why?
|
| Ghrelin | 1 | 2024 | 53 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 1622 | 0.050 |
Why?
|
| Exons | 3 | 2016 | 833 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2024 | 48 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 78 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 64 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 298 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2018 | 3162 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 91 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 839 | 0.050 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2024 | 175 | 0.050 |
Why?
|
| Vincristine | 1 | 2024 | 195 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 3055 | 0.050 |
Why?
|
| Pedigree | 2 | 2020 | 1694 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 317 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 452 | 0.050 |
Why?
|
| Oxycodone | 1 | 2022 | 12 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 181 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2022 | 69 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2024 | 836 | 0.050 |
Why?
|
| Eating | 1 | 2024 | 387 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 240 | 0.050 |
Why?
|
| Relative Biological Effectiveness | 1 | 2021 | 7 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2021 | 41 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2018 | 783 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 438 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2021 | 58 | 0.040 |
Why?
|
| Machine Learning | 1 | 2024 | 326 | 0.040 |
Why?
|
| Species Specificity | 2 | 2013 | 571 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2003 | 778 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 29321 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 125 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 406 | 0.040 |
Why?
|
| Carbon | 1 | 2021 | 99 | 0.040 |
Why?
|
| HIV | 1 | 2022 | 195 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2022 | 334 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2003 | 538 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 2 | 2014 | 473 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 233 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 823 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1326 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Phylogeny | 1 | 2022 | 787 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 2 | 2009 | 18 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 352 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 775 | 0.040 |
Why?
|
| Rad51 Recombinase | 1 | 2019 | 32 | 0.040 |
Why?
|
| Aged | 4 | 2024 | 21685 | 0.040 |
Why?
|
| Gene Drive Technology | 1 | 2019 | 6 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1846 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2022 | 407 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2020 | 198 | 0.040 |
Why?
|
| gamma-Globins | 1 | 2018 | 3 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 417 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 224 | 0.040 |
Why?
|
| Methylation | 1 | 2019 | 231 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 100 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 142 | 0.040 |
Why?
|
| RNA Precursors | 1 | 2018 | 65 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2014 | 626 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 336 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 327 | 0.040 |
Why?
|
| Adenosine | 1 | 2019 | 139 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2018 | 198 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 1334 | 0.040 |
Why?
|
| Cytochromes | 1 | 2017 | 6 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 152 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 31907 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 718 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 218 | 0.030 |
Why?
|
| Chimera | 1 | 2017 | 83 | 0.030 |
Why?
|
| HIV Protease Inhibitors | 1 | 2017 | 46 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 296 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2019 | 250 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 458 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 176 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 444 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3970 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 5 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 231 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2016 | 17 | 0.030 |
Why?
|
| United States | 2 | 2024 | 11656 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1301 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 266 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2019 | 561 | 0.030 |
Why?
|
| Hydrolases | 1 | 2016 | 57 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2016 | 101 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 1594 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2015 | 38 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1596 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 17446 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1304 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 568 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2016 | 230 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3689 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1134 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 896 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 823 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 349 | 0.030 |
Why?
|
| Weaning | 1 | 2014 | 49 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 182 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 563 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2015 | 371 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 20539 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 138 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2014 | 94 | 0.030 |
Why?
|
| Decision Trees | 1 | 2013 | 52 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 107 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 2935 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 139 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 605 | 0.030 |
Why?
|
| Replication Protein A | 1 | 2013 | 10 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2013 | 145 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 433 | 0.030 |
Why?
|
| Argonaute Proteins | 1 | 2013 | 31 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2013 | 90 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 790 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 577 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3392 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1136 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2012 | 199 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2018 | 1146 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2805 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 715 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 72 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 811 | 0.020 |
Why?
|
| DNA Probes | 1 | 2009 | 125 | 0.020 |
Why?
|
| Mitosis | 1 | 2010 | 194 | 0.020 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2009 | 19 | 0.020 |
Why?
|
| DNA Damage | 1 | 2013 | 542 | 0.020 |
Why?
|
| Haplorhini | 1 | 2009 | 122 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2009 | 37 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5495 | 0.020 |
Why?
|
| Transcription Factor HES-1 | 1 | 2008 | 20 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 216 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6579 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 551 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 2200 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3418 | 0.020 |
Why?
|
| DNA Replication | 1 | 2010 | 362 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3636 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 800 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2525 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2785 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12990 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 216 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 724 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2009 | 362 | 0.020 |
Why?
|
| Systems Integration | 1 | 2007 | 28 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3475 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4528 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 406 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 1303 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 454 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 710 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 403 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2005 | 121 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 107 | 0.010 |
Why?
|
| Testis | 1 | 2007 | 426 | 0.010 |
Why?
|
| Lung | 1 | 2012 | 1555 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2004 | 33 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 506 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 505 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 1871 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 789 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 1059 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 482 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 1054 | 0.010 |
Why?
|